Pharmicell Co. Ltd. | Mutual Funds
Mutual Funds that own Pharmicell Co. Ltd.
Vanguard Total International Stock Index Fund
741,383
1.24%
33,909
0%
07/31/2018
Vanguard Developed Markets Index Fund
286,614
0.48%
0
0%
07/31/2018
Vanguard FTSE All World (ex-US) Small Cap
125,146
0.21%
0
0.03%
07/31/2018
Mirae Asset TIGER Health Care ETF
113,619
0.19%
27,590
1.24%
04/30/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
91,050
0.15%
0
0.02%
09/05/2018
DFA Emerging Markets Small Cap Series
85,904
0.14%
0
0.02%
01/31/2018
Schwab International Small Cap Equity ETF
67,829
0.11%
0
0.05%
09/06/2018
SPDR S&P International Small Cap ETF
64,040
0.11%
0
0.12%
09/06/2018
Vanguard Pacific Stock Index Fund
55,760
0.09%
0
0.01%
07/31/2018
iShares III Plc - MSCI Emerging Markets Small Cap
32,860
0.06%
0
0.13%
09/05/2018
| Address |
7/F, Sang-Bong Building
Seoul SL 06017
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.pharmicell.com |
| Updated |
07/08/2019 |
| Pharmicell Co., Ltd. is engaged in the development of stem cell based pharmaceuticals and technologies. It operates through Bio and Chemical Business Divisions. The Bio division provides cosmetics, cell for researches, medical testing equipment, and others. |
